ClinicalTrials.gg
Not yet recruitingNCT07783139Updated Aug 24, 2026

Massage, Sleep , and Pain

An interventional study of Semi-Standardized Integrative Therapeutic Massage and Usual Care in Chronic Musculoskeletal Pain and Sleep Disturbances, sponsored by Defense and Veterans Center for Integrative Pain Management. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-08-24.

Sponsored by Defense and Veterans Center for Integrative Pain Management · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

This study evaluates whether a 6-week semi-standardized integrative therapeutic massage intervention improves sleep quality and pain outcomes compared with usual care in active-duty service members with chronic back, neck, or shoulder pain.

Read the detailed description

Chronic musculoskeletal pain and sleep disturbances are highly prevalent among active-duty military personnel and adversely affect force readiness and operational performance. Sleep and pain are bidirectionally linked: poor sleep amplifies pain perception, while pain disrupts sleep quality. Massage therapy is widely utilized for pain relief, but the mechanisms driving improvement remain unclear. This study evaluates whether a 6-week semi-standardized integrative therapeutic massage intervention improves sleep quality and pain outcomes compared with usual care in active-duty service members with chronic back, neck, or shoulder pain. Objective sleep parameters will be tracked continuously using wrist actigraphy alongside prospective daily sleep and pain diaries. The study also explores whether sleep changes statistically mediate pain relief.

02

Conditions studied

  • Chronic Musculoskeletal Pain
  • Sleep Disturbances

Browse trials for

Keywords

  • massage therapy
  • chronic pain
  • sleep disturbances
  • actigraphy
  • military personnel
03

In context

Chronic Pain

3,227 studies on the registry are indexed under Chronic Pain; 729 are open to participants now.

This study's planned enrollment of 120 is above the median of 60 across 2,388 interventional studies indexed under Chronic Pain.

Browse Chronic Pain studies →

Lead sponsor

Defense and Veterans Center for Integrative Pain Management is the lead sponsor of 22 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria: Active-duty military service member Age 18 to 60 years Self-reported chronic back, neck, or shoulder pain for at least 3 m onths (≥3 months) Baseline pain severity score of 4 or greater (DVPRS ≥4) Able to read and understand English Access to a smartphone, tablet, or computer for survey completion -

Exclusion Criteria: Criteria:Provider recommendation against massage therapy Undergone surgery within the prior 3 months Pregnancy Received clinical massage therapy within the prior 12 months Diagnosed with Complex Regional Pain Syndrome (CRPS), Fibromyalgia, Chronic Fatigue Syndrome, disease-related pain, Advanced neuropathies, or Active cancer-related pain Diagnosed Obstructive Sleep Apnea (OSA) that is untreated or non-adherent with therapy History of severe traumatic brain injury (TBI) Severe psychiatric di sorder Inability to provide or attend weekly sessions at WRNMMC

-

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Massage Therapy + Usual Care

    6 weeks of semi-standardized integrative therapeutic massage

    Behavioral: Semi-Standardized Integrative Therapeutic Massage

  • Active comparator
    Usual Care Alone (Wait-List Control)

    continue standard provider-prescribed medical and rehabilitative care alone for 12 weeks,

    Other: Usual Care

Interventions

  • BehavioralSemi-Standardized Integrative Therapeutic Massage

    45-minute sessions delivered by a licensed therapist incorporating 15 minutes of head/neck nervous system calming followed by Swedish techniques, myofascial release, passive range of motion, and localized trigger point work using moderate pressure.

  • OtherUsual Care

    Standard pharmacologic, physical therapy, and medical management directed by primary care or specialty providers.

06

What researchers measure

Primary outcomes

  1. Change from Baseline in Pain Intensity on Defense and Veterans Pain Rating Scale (DVPRS)

    Self-reported pain severity measured on a 0-10 numeric rating scale (0 = no pain, 10 = worst possible pain). Primary endpoint is change from Week 0 to Week 8.

    Time frame: Baseline (Week 0), weekly during intervention (Weeks 1-6), Post-treatment (Week 8), and Follow-up (Week 12).

  2. Change from Baseline in Actigraphy-Derived Sleep Efficiency

    Objective sleep quality measured via continuous wrist actigraphy, calculated as the percentage of time spent asleep relative to total time spent in bed.

    Time frame: Week 0 through Week 8.

Secondary outcomes

  1. Change from Baseline in Insomnia Severity Index (ISI) Total Score

    7-item questionnaire evaluating the severity of sleep onset, sleep maintenance, and daytime impact of insomnia symptoms (score range: 0-28, higher scores indicate greater insomnia severity).

    Time frame: Baseline (Week 0), Weeks 2, 4, 6, 8, and 12

  2. Change from Baseline in Pittsburgh Sleep Quality Index (PSQI) Global Score

    Self-report questionnaire evaluating 7 domains of sleep quality over the past month (score range: 0-21, higher scores indicate worse sleep quality).

    Time frame: Baseline (Week 0), Week 4, Week 8, and Week

Other outcomes

  1. Change from Baseline in PROMIS-29 Domain T-Scores

    Standardized measures assessing pain interference, physical function, fatigue, sleep disturbance, anxiety, and depression (scored using T-scores, Mean = 50, SD = 10).

    Time frame: Baseline (Week 0), weekly through Week 8, and

  2. Change from Baseline in Pain Catastrophizing (UW-CAP SF-6 T-Score)

    6-item short form measuring distressing thoughts and hopelessness associated with pain (standardized T-score, Mean = 50, SD = 10).

    Time frame: Baseline (Week 0), weekly through Week 8, and Week 12

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be made publicly available or shared for future secondary research studies outside authorized institutional agreements. Coded research data will be maintained on secure servers for 7 years post-study per institutional guidelines.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Sep 2028, 23 months later.

Of 1,295 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's planned 23 months is above that.

Counting every sponsor, half of 1,378 studies reached it within 20 months; a quarter within 9 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 20, 2026
First posted
Aug 24, 2026
StartEst.
Oct 1, 2026
Primary completionEst.
Sep 2028
CompletionEst.
Sep 2028
Last update
Aug 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07783139
Lead sponsor
Defense and Veterans Center for Integrative Pain Management
Responsible party
Sponsor
First posted
Aug 24, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Sep 2028 (estimated)
Completion
Sep 2028 (estimated)
Last update
Aug 24, 2026

Study contacts

Mary McDuffie, MS RN BSN
Contact
mary.mcduffie.ctr@usuhs.edu
3015388785
Tracy Rupp, PhD
study chair · USU/DVCIPM

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion